Incidence and prognosis in early onset breast cancer

被引:42
作者
Sundquist, M
Thorstenson, S
Brudin, L
Wingren, S
Nordenskjöld, B
机构
[1] Cty Hosp, Dept Surg, Kalmar, Sweden
[2] Cty Hosp, Dept Pathol & Cytol, Kalmar, Sweden
[3] Univ Hosp, Dept Oncol, Linkoping, Sweden
关键词
D O I
10.1054/brst.2001.0358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the incidence and prognosis in early onset breast cancer. Age-adjusted incidence and death rate for the 5394 Swedish women diagnosed with breast cancer under the age of 40 between 1960 and 1996 was studied using data from the Swedish Cancer Registry and Swedish Death Cause Registry. A total of 107 consecutive young patients with invasive breast cancer undergoing surgery during 1980-1993 in the Southeast Swedish health care region were retrospectively followed up and their cancers reviewed and graded blindly. The median follow-up time was 11.2 years. The applicability of the Nottingham Prognostic Index (NPI) as a prognostic tool was investigated. Grade, age, node status, tumour size, S-phase fraction and steroid receptor content were related to survival univariately and multivariately in a Cox proportional hazard analysis. The incidence of early onset breast cancer has increased moderately and the survival rate has not improved during the last 35 years. When young women are diagnosed with breast cancer their tumours are larger, their lymph nodes more often involved, and the median grade higher than in older with 64% having grade 3 tumours. Lymph node status was the strongest sole prognostic indicator but the use of NPI gave more accurate prognostic information than node status alone. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 39 条
[1]   Inherited BRCA2 mutation associated with high grade breast cancer [J].
Agnarsson, BA ;
Jonasson, JG ;
Björnsdottir, IB ;
Barkardottir, RB ;
Egilsson, V ;
Sigurdsson, H .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (02) :121-127
[2]   PROGNOSIS AFTER BREAST-CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY [J].
BERGKVIST, L ;
ADAMI, HO ;
PERSSON, I ;
BERGSTROM, R ;
KRUSEMO, UB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (02) :221-228
[3]  
Bertheau P, 1999, SEMIN DIAGN PATHOL, V16, P248
[4]  
Bonnier P, 1998, INT J CANCER, V79, P278
[5]   CLINICAL AND BIOLOGIC PROGNOSTIC FACTORS IN BREAST-CANCER DIAGNOSED DURING POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY [J].
BONNIER, P ;
ROMAIN, S ;
GIACALONE, PL ;
LAFFARGUE, F ;
MARTIN, PM ;
PIANA, L .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (01) :11-17
[6]   AGE AS A PROGNOSTIC FACTOR IN BREAST-CANCER - RELATIONSHIP TO PATHOLOGICAL AND BIOLOGIC FEATURES [J].
BONNIER, P ;
ROMAIN, S ;
CHARPIN, C ;
LEJEUNE, C ;
TUBIANA, N ;
MARTIN, PM ;
PIANA, L .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (02) :138-144
[7]  
Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO
[8]  
2-3
[9]  
COLDITZ GA, 1995, CANCER EPIDEM BIOMAR, V4, P567
[10]   Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: A 10-year follow-up [J].
Cowen, D ;
Jacquemier, J ;
Houvenaeghel, G ;
Viens, P ;
Puig, B ;
Bardou, VJ ;
Resbeut, M ;
Maraninchi, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04) :801-807